The Fibroblast Growth Factor 2

Publicado by on 27 feb 2013 in inglés, Publicaciones Médicas | 0 comments

The Fibroblast Growth Factor 2 (FGF2) Improves VEPs in Autistic Children.

Recent Advances in Human Neurophysiology.
March 1998. Okazaki, Japan.
AGUILAR L. C., CRUZ S., MARTIN R., ROSIQUE P., ALFARO F., ISLAS A., AND CANTU J.M.

Instituto de Investigaciones en Neuroplasticidad y Desarrollo Celular . Departamento de Biologia Celular y Molecular de la Universidad de Guadalajara. CIBO, IMSS. Guadalajara, Jalisco, MEXICO A.P. 3920.

INTRODUCTION

FGF2 is a protein that has shown neurotrophic effect in many areas of the embryonic (Eckenstein et.al., 1990. Weise et. al., 1993), foetal (Walicke et. al., 1986. Morrison et. al., 1986. . Deloulme, et. al., 1991) and adult brain( Matsuda et al. 1990). Its in vitro effects include survival, neurite extension (Peulve P. Et. al., 1994), increase in choline acetyltransferase (CAT) activity, dopamine levels (Aguilar et. al. 1994a).
In several animal models of brain damage as trauma (Mocchetti et. al. 1995, Anderson et. al., 1988), hypoxia/ischemia (Aguilar et. al., 1994ª, Nakata et. al., 1993), kainic acid (Rudge et. al., 1995), and pathway sections (Koshinaga et. al., 1993), etc.) have shown that the FGF2 is capable of diminishing the degree of lesion. Studies in which FGF2 was administered after damage (Anderson et. al., 1988), showed a significant improvement in morphological, neurochemical (Otto, D. and Unsicker, K. 1990.) and neurophysiological (Aguilar et. al. 1994a) parameters. Previous clinical studies in intellectual disabilities showed a significant improvement in mental retardation (Aguilar et. al., 1993) and language disabilities (Aguilar et. al.,1994b).

Symmetry analysis of Flash VEPs, in previous studies carried out by our group, demonstrates to be a reliable and objective procedure for quantifying abnormalities in autistic children, when using Pearson Coefficient (PC) to analyse interhemispheric linear correlation and Energy Ratio (ER) to compare the voltage generated in a specific segment of time(area below the curve) in both hemispheres.

METHODS

With the purpose of improving the impairment of autistic children, FGF2 was used, applied subcutaneously at dosage of 0.2 mg/kg, every two weeks during 12 months. The autistic group (n=29, both sexes between 3 and 8 years of age), was studied using flash VEPs, with 16 electrodes placed according to 10-20 international system. VEPs were analysed in 2 segments, 50-200 and 200-400 ms through PC and ER, PC was expressed as a value between 1 and –1, the values lower than 0.7, were considered as significant deviations (p<0.025) when compared to control healthy group (CHG) and ER was expressed as a ratio in which the higher value of one area ( any side) was normalised to 1 and the contra lateral as a ratio, the values lower 0.4 were significant deviated (p<0.025) of a CHG indicating asymmetry. The areas that in the initial study showed significant deviations (P<0.025) respect to normal group were totalled and compared before vs. after 12 month of treatment, trough t-test.

RESULTS

The symmetry of area below the curve or ER in P3-P4 and O1-O2 showed significant increase (p<0.004) in segment 50-200 ms (Fig. 1) and in 200-400 ms segment, P3-P4 and T5-T6 (P<0.004) increase after 12 months of treatment (Fig. 1). P3-P4 and T5-T6 showed in the initial study the grater number of asymmetries in PC mainly in 200-400 ms segment and after FGF2 treatment a significant reduction (p<0.01) was observed in all areas in both segments (Fig. 2).

Fig. 1. Energy Radio (ER) before and after FGF2 Therapy in Autistic Children. Observe the significant increase

Fig. 2. Deviations in Pearson Coefficient (PC) before and after 12 months of FGF2 Therapy in Autistic Children. Observe the significant reduction (P<0.01)

DISCUSSION AND CONCLUSIONS

The parietals (P3-P4) improved significantly in ER and less in PC (p<0.08), this probably due to the fact, that first the number of responding neurones increase and then the functional organisation, in general the improvement was higher in ER that in PC. T5-T6 increase significantly in 200-400 ms in both symmetry analysis (ER and PC) indicating improvement in the late components of this regions, probably related to the fact that the best response in neuropsychological evaluation was in language, function highly related with temporal regions (Head, H. 1926).
TWe conclude that FGF2 improves flash VEPs mainly in parietal, temporal and occipital regions of autistic children after 12 months of treatment (Fig 3 a, 3 b, 4 a and 4 b), this correlated with improving in language, visual motor maturation and social behaviour, areas that showed the best evolution in the neuropsychological evaluation. The most noticeable improvement was the recovery of the area below the curve in many patients in which the initial study showed absence or very low response in parietal, temporal and occipital regions mainly in the right side (Fig. 3 a and 3 b).

Fig. 3 a. Notice the absence of response in O2 and reduction of voltage in T6 and P4, respect to contra lateral regions in autistic child ( male, 4 years old).

Fig. 3 b. Notice the recovery in voltage and area below the curve in O2, T6 and P4, also observe that the Pearson coefficient increase in the same autistic patient after 12 months of FGF2 therapy.

Fig. 4 a. Observe the low Pearson coefficient and the asymmetries in area below the curve in P3-P4, O1-O2 and T5-T6.

Fig. 4 b. Notice the increase in Pearson coefficient and reduction of asymmetries in voltage (energy ratio) in P3-P4, O1-O2 and T5-T6 after 12 months of FGF2 treatment.

REFERENCES

Aguilar_LC; Islas_A; Rosique_P; Hernandez_B; Portillo_E; Herrera_JM; Cortes_R; Cruz_S; Alfaro_F; Martin_R; et_al Psychometric analysis in children with mental retardation due to perinatal hypoxia treated with fibroblast growth factor (FGF) and showing improvement in mental development. J Intellect Disabil Res, 1993 Dec, 37 ( Pt 6):, 507-20

Aguilar, L.C., Islas, A., Morales, A., Alfaro, F., Cruz, S., Martin, R., and Cantu, J.M. 1994a. Estudios preclinicos de la administración del Factor de Crecimiento Fibroblástico en daño cerebral. Capitulo VI. 83-94. En Avances en la Restauración del Sistema Nervioso. Aguilar-Rebolledo, F. Ed. Vicova Editores.

Aguilar, L.C., Rosique, P., Cruz, S., Martin, M., Alfaro, F., Islas, A., and Cantu, J.M. 1994b. Administración del factor Fibroblástico de Crecimiento en disfunciones neurológicas consecutivas a hipóxia-isquemia perinatal. Capitulo VII. 95-106. En Avances en la Restauración del Sistema Nervioso. Aguilar-Rebolledo, F. Ed. Vicova Editores.

Anderson, K.J., Dam, D., Lee, S. and Cotman, C.W. 1988. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 332:360-361.

Deloulme_JC; Baudier_J; Sensenbrenner_M Establishment of pure neuronal cultures from fetal rat spinal cord and proliferation of the neuronal precursor cells in the presence of fibroblast growth factor. J Neurosci Res, 1991 Aug, 29:4, 499-509.

Eckenstein_FP; Esch_F; Holbert_T; Blacher_RW; Nishi_R Purification and characterisation of a trophic factor for embryonic peripheral neurons: comparison with fibroblast growth factors.
Neuron, 1990 Apr, 4:4, 623-31.

Head, H. (1926). Aphasia and kindred disorders of speech. Cambridge; Cambridge University Press.

Koshinaga_M; Sanon_HR; Whittemore_SR Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp Neurol, 1993 Mar, 120:1, 32-48

Matsuda, S., Saito, H. and Nishiyama, N. 1990. Effect of basic growth factor on neurons cultured from various regions of postnatal rat brain. Brain Res. 520: 310-316.

Mocchetti_I; Wrathall_JR Neurotrophic factors in central nervous system trauma. J Neurotrauma, 1995 Oct, 12:5, 853-70

Morrison, R.S., Sharma A., de Vellis, J. and Bradshaw

R.A. 1986. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA. 83:75377541.

Nakata_N; Kato_H; Kogure_K Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res, 1993 Mar 12, 605:2, 354-6

Otto, D. and Unsicker, K. 1990. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10:1912-1921.

Peulve_P; Laquerriere_A; Hemet_J; Tadie_M Comparative effect of alpha-MSH and b-FGF on neurite extension of fetal rat spinal cord neurons in culture. Brain Res, 1994 Aug 22, 654:2, 319-23

Rudge_JS; Pasnikowski_EM; Holst_P; Lindsay_RM Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid. J Neurosci, 1995 Oct, 15:10, 6856-67

Walicke, P., Cowan, W.M., Ueno, N., Baird, A. and Guillemin R. 1986. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. USA. 83:3012-3016.

Walicke, P.A. 1988. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8:2618-2627.

Weise_B; Janet_T; Grothe_C Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J Neurosci Res, 1993 Mar 1, 34:4, 442-53

Comentarios

Dejar un comentario